Aaron Klaiber

Carl von Ossietzky Universität Oldenburg — Germany

Psychology · Social Sciences

10h-index569citations20works6.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Psychedelics and Drug Studies(16), Neurotransmitter Receptor Influence on Behavior(8), Chemical synthesis and alkaloids(8), Forensic Toxicology and Drug Analysis(4), Biochemical Analysis and Sensing Techniques(4)

Publications20 total

Pharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants
Clinical Pharmacokinetics·2025· 1 citedOpen Access
Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers
Psychopharmacology·2025Open Access
Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults
JAMA Psychiatry·2025· 7 citedOpen Access
Spatial distribution and functional integration of displaced retinal ganglion cells
Scientific Reports·2025· 12 citedOpen Access
Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants
Neuropsychopharmacology·2024· 9 citedOpen Access
Safety pharmacology of acute mescaline administration in healthy participants
British Journal of Clinical Pharmacology·2024· 2 citedOpen Access
Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects
Translational Psychiatry·2024· 16 citedOpen Access
Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants
Neuropsychopharmacology·2024· 14 citedOpen Access
Safety pharmacology of acute mescaline administration in healthy participants
Neuroscience Applied·2024Open Access
Acute effects of individual R- and S-MDMA enantiomer administration compared with racemic (±)-MDMA in healthy participants
Neuroscience Applied·2024Open Access
Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants
Neuropsychopharmacology·2023· 35 citedOpen Access
Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants
Neuropsychopharmacology·2023· 109 citedOpen Access
Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants
Translational Psychiatry·2023· 74 citedOpen Access
The association between real-life markers of phone use and cognitive performance, health-related quality of life and sleep
Environmental Research·2023· 15 citedOpen Access
Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants
Neuroscience Applied·2023· 1 citedOpen Access
Acute effects of MDMA and LSD co-administration in healthy participants
Neuroscience Applied·2023Open Access
Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants
The International Journal of Neuropsychopharmacology·2022· 88 citedOpen Access
Development and validation of an LC-MS/MS method for the quantification of mescaline and major metabolites in human plasma
Journal of Pharmaceutical and Biomedical Analysis·2022· 23 citedOpen Access
Ketanserin reverses the acute effects of LSD in healthy subjects
Neuroscience Applied·2022Open Access
Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects
Clinical Pharmacology & Therapeutics·2021· 163 citedOpen Access

Frequent Co-authors

Matthias E. Liechti(18), A. Becker(13), Laura Ley(10), Isabelle Straumann(10), Friederike Holze(9), Urs Duthaler(9), Anne Eckert(9), Dino Luethi(9), Nimmy Varghese(7), Yasmin Schmid(6), Deborah Rudin(5), Jan Thomann(4), Severin B. Vogt(4), Livio Erne(4), Lorenz Mueller(3), Denis Arikci(2), Ioanna Istampoulouoglou(2), Isidora Avedisian(2), Mélusine Humbert‐Droz(2), N. Varghese(2)